Ben Chandler
LightNews LightNews
banner
benjaminhchandler.com
Ben Chandler
@benjaminhchandler.com
180 followers 420 following 4 posts
Postbac research fellow at NIMH and aspiring psychiatrist-neuroscientist. Cat dad to Tipper 😻. MI → DC. Views are my own.
benjaminhchandler.com
Posts Replies Media Videos
Reposted by Ben Chandler
apapsychiatric.bsky.social
Ketamine: The Story of Modern Psychiatry's Most Fascinating Molecule is meticulously researched, engagingly written, and comprehensive in scope. bit.ly/4kI6QHj
June 20, 2025 at 9:21 PM
Reposted by Ben Chandler
neselsd.bsky.social
My personal response to the propagandistic & defamatory New York Times article on Psymposia @psymposia.bsky.social, which violated the Times' editorial standards. This transparently partisan attack politicized whistleblowers to appeal to the Trump administration on behalf of a pharmaceutical company
It's disappointing — but not surprising — that journalists with close ties to MAPS have resorted to such a transparently partisan political attack. This piece is an opportunistic attempt to politicize whistleblowers with a narrative that appeals to the Trump administration. While Jacobs and Nuwer attack Psymposia and me personally, they have failed to refute our core claims, which remain important and unrebutted. To be clear, their attacks are flatly incorrect and underscore their desperation to distract from the real story: that MAPS’s handling of its clinical trials was a disaster, and that Lykos is in financial disarray. To obscure this fact, the article offered a caricature of my research and of Psymposia's broader work in the field. I describe my actual motivations in a recent AJOB commentary: Lykos has never acknowledged how the on-camera physical and sexual abuse from its Phase 2 clinical trial was enabled by the therapy's reliance on Grofian “focused bodywork.” The Phase 2 participant had tried to alert the FDA to this connection for years, and it was only after those initial attempts were unsuccessful that we felt obligated to communicate this to the advisory committee, before this dangerous practice could be scaled. If MAPS had listened to this participant’s concerns when the abuse took place, they could have made their therapy safer years ago. I am not opposed to the psychedelic industry, but to the normalization of pseudoscientific practices when vulnerable groups are at stake.
February 6, 2025 at 6:34 PM
benjaminhchandler.com
I’m intrigued 🧐 it makes sense!
trpwolff.bsky.social Max Wolff @trpwolff.bsky.social · Jun 16
Reframing Psychedelic Regulation: Tools, not Treatments

In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right.

The use of anesthetics as treatment tools in surgery is a useful analogy.
Drug Science, Policy and Law Screenshot of title page and abstract
June 16, 2025 at 11:08 PM
benjaminhchandler.com
Keep your eyes peeled for “Resting-state spectral power markers of insular dysregulation in suicide attempt history” 👀 @sfn.org #SfN2025
June 8, 2025 at 11:47 PM
benjaminhchandler.com
My undergraduate thesis "Examining the effects of estradiol and COMT polymorphism on a neural correlate of error awareness" (2023) is now available on @researchgate.bsky.social:

www.researchgate.net/publication/...
(PDF) Examining the effects of estradiol and COMT polymorphism on a neural correlate of error awareness [Undergraduate thesis, Michigan State University]
PDF | A two-semester independent study project under the supervision of the principal investigator (Jason S. Moser, Ph.D.) and a clinical psychology... | Find, read and cite all the research you need ...
www.researchgate.net
June 8, 2025 at 11:46 PM